Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Janus

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Australian Family Physician|February 1, 1993
Current issues in the treatment of hyperlipidaemiasE D Janus
Pathology|July 1, 1993
Apolipoprotein(a) and atherogenesisE D Janus
Clinical and Experimental Pharmacology & Physiology|December 24, 1997
Epidemiology of cardiovascular risk factors in Hong KongE D Janus
Australian Family Physician|September 1, 1989
Treatment of hyperlipidaemias. Current avenues and new horizonsE D Janus
Heart, Lung & Circulation|December 15, 2005
Burgeoning atherosclerosis in AsiaE D Janus
Chest|August 1, 1988
Alpha 1-antitrypsin Pi types in COPD patientsE D Janus
Clinics in Endocrinology and Metabolism|July 1, 1978
Alcohol and abnormalities of lipid metabolismE D Janus, B Lewis
Australian and New Zealand Journal of Medicine|December 1, 1990
Alpha-1-antitrypsin deficiency and emphysema: new horizons in treatmentE D Janus, J G Burdon
Australasian Physical & Engineering Sciences in Medicine|October 1, 1983
Deconvolution in the study of lipoprotein metabolismJ H Bates, E D Janus
The New Zealand Medical Journal|May 28, 1975
Alpha-1-antitrypsin deficiency in New ZealandE D Janus, R W Carrell
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Australian Family Physician|February 1, 1993
Current issues in the treatment of hyperlipidaemiasE D Janus
Pathology|July 1, 1993
Apolipoprotein(a) and atherogenesisE D Janus
Clinical and Experimental Pharmacology & Physiology|December 24, 1997
Epidemiology of cardiovascular risk factors in Hong KongE D Janus
Australian Family Physician|September 1, 1989
Treatment of hyperlipidaemias. Current avenues and new horizonsE D Janus
Heart, Lung & Circulation|December 15, 2005
Burgeoning atherosclerosis in AsiaE D Janus
Chest|August 1, 1988
Alpha 1-antitrypsin Pi types in COPD patientsE D Janus
Clinics in Endocrinology and Metabolism|July 1, 1978
Alcohol and abnormalities of lipid metabolismE D Janus, B Lewis
Australian and New Zealand Journal of Medicine|December 1, 1990
Alpha-1-antitrypsin deficiency and emphysema: new horizons in treatmentE D Janus, J G Burdon
Australasian Physical & Engineering Sciences in Medicine|October 1, 1983
Deconvolution in the study of lipoprotein metabolismJ H Bates, E D Janus
The New Zealand Medical Journal|May 28, 1975
Alpha-1-antitrypsin deficiency in New ZealandE D Janus, R W Carrell
Pageof 10